Robenacoxib-d5

• Description:

  Robenacoxib-d5 is deuterium-labeled Robenacoxib (HY-118078) [1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302, H361, H412

• Target:

  COX; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Immunology/Inflammation; Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Purity:

  99.56

• Smiles:

  O=C(CC1=CC(C([2H])([2H])C([2H])([2H])[2H])=CC=C1NC2=C(C(F)=CC(F)=C2F)F)O

• Molecular Formula:

  C16H8D5F4NO2

• Molecular Weight:

  332.30

• Precautions:

  H302, H361, H412

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133 (3) : 366-391.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, protect from light)

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  [2012598-81-9]